EPHB2 and cervical carcinoma: The applied approach identified already-known biomarkers, tumor suppressors, and oncogenes in cervical cancer, as well as novel candidates such as KAT2B, PARP1, CDK1, GSK3B, WNK1, CRYAB, CCR6, EPHB2, NR2C1, NR2C2 and CUTL1.